Drug Repurposing is an enticing market with surging growth forecasts. The orphan class of biological products deserves special attention for drug repurposing as it provides a vital niche to the patient and society and are currently minimally investigated.

clinical trials tag icon Tags: | | |
– Boston Biotech Clinical Research (BBCR). Strategic Clinical Innovation Experts. Rare Disease, Clinical Trials, Clinical Research, & Biologics. We work with biotech, pharmaceutical, and device companies to develop clinical/regulatory road-maps consisting with simplified clinical programs, streamlined protocols, and cost-effective clinical trials. Our experienced team provides innovative strategies that meet your goals.

by | Mar 1, 2022 | Real World Evidence, Strategy and TPP

Drug Repurposing is an enticing market with surging growth forecasts. The orphan class of biological products deserves special attention for drug repurposing as it provides a vital niche to the patient and society and are currently minimally investigated.

If you’re interested in learning more about drug repurposing to treat rare disease, BBCR can help with your regulatory consulting needs. We offer expertise in the following areas:

  • FDA meeting and submission
  • Pre-IND integrated development plan
  • Clinical consultant
  • Clinical study design and protocol
  • CRO and project management
  • Study remediation and rescue

Learn more about BBCR

 

 

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

Pin It on Pinterest